August 14, 2018 NeoGenomics Follow-On Offering
August 2, 2018 Davis Polk Advises Pernix on Private Exchange Offers
July 18, 2018 Davis Polk Advises Auris Medical Holding AG on Its Offering of Common Shares and Warrants
July 2, 2018 Davis Polk Advises Entera Bio Ltd. on Its Initial Public Offering
June 19, 2018 General Motors Financial Company, Inc. $1 Billion Senior Notes Offering
June 14, 2018 Davis Polk Advises Kadmon Holdings, Inc. on Its Follow-on Offering of Common Stock
June 4, 2018 Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $2.05 Billion Refinancing
May 30, 2018 Iterum Therapeutics plc Initial Public Offering
May 16, 2018 $1.5 Billion Bank Financing for The J.M. Smucker Company’s Acquisition of Ainsworth Pet Nutrition Parent, LLC
April 10, 2018 General Motors Financial Company, Inc. $2.5 Billion Senior Notes Offering
March 26, 2018 Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $1.5 Billion Refinancing
March 2, 2018 General Motors Company $1.59 Billion Secondary Offering
February 16, 2018 Avadel Pharmaceuticals $143.7 Million Exchangeable Senior Notes Offering
February 15, 2018 Davis Polk Advises Affimed on Its $26.5 Million Offering of Shares
January 30, 2018 Davis Polk Advises Auris Medical Holding AG on Its Registered Offering of Common Shares and Concurrent Private Placement of Warrants to Purchase Common Shares
January 5, 2018 General Motors Financial Company, Inc. $1.65 Billion Senior Notes Offering
December 7, 2017 The J. M. Smucker Company $800 Million Notes Offering
November 14, 2017 Bandwidth Inc. Initial Public Offering
November 10, 2017 Insulet Corporation Convertible Senior Notes Offering
November 10, 2017 Davis Polk Advises InflaRx N.V. on Its Initial Public Offering
November 7, 2017 General Motors Financial Company, Inc. $2 Billion Senior Notes Offering
November 6, 2017 Allena Pharmaceuticals Initial Public Offering
October 20, 2017 Davis Polk Advises Auris Medical Holding AG on Its Registered Offering of Common Shares and Equity Line of Financing
September 28, 2017 Davis Polk Advises Kadmon Holdings, Inc. on Its Follow-on Offerings of Common Stock and Warrants to Purchase Common Stock
September 20, 2017 General Motors Financial Company, Inc. $1 Billion Preferred Stock Offering
August 7, 2017 General Motors Company $3 Billion Senior Notes Offering
July 26, 2017 Davis Polk Advises Pernix Therapeutics Holdings, Inc. on Its Refinancing Transactions
June 30, 2017 General Motors Financial Company, Inc. $2.25 Billion Senior Notes Offering
June 23, 2017 Bristol-Myers Squibb Company Debt Tender Offer
June 21, 2017 Coach, Inc. $1 Billion Senior Notes Offering
June 21, 2017 General Motors Financial Company, Inc. Establishment of $6 Billion Term Notes Program
May 9, 2017 General Motors Financial Company, Inc. $750 Million Senior Notes Reopening
April 13, 2017 General Motors Financial Company, Inc. $3 Billion Senior Notes Offering
March 28, 2017 Medtronic $2 Billion Notes Offering
March 21, 2017 Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $6.25 Billion Refinancing
March 15, 2017 Western Union $400 Million Notes Offering
February 21, 2017 Davis Polk Advises Auris Medical Holding AG on Its Offering of Common Shares and Warrants to Purchase Common Shares
January 25, 2017 Davis Polk Advises Affimed on Its $18 Million Offering of Shares
January 17, 2017 General Motors Financial Company, Inc. $2.5 Billion Senior Notes Offering
January 10, 2017 Summit Materials $237 Million Common Stock Offering
December 27, 2016 Sucampo Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
April 1, 2016 Four Davis Polk Partners Named “Rising Stars” by Law360
News Search: